Adenosine and Ticagrelor Plasma Levels in Patients With and Without Ticagrelor-Related Dyspnea.

• Ortega-Paz L Cardiovascular Clinic Institute, Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Spain (L.O-P., S.B.).
• Brugaletta S Cardiovascular Clinic Institute, Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Spain (L.O-P., S.B.).
• Ariotti S Swiss Cardiovascular Center Bern, Bern University Hospital (S.A., S.W., M.V.).
• Akkerhuis KM Erasmus University Medical Center, Rotterdam, Netherlands (K.M.A.).
• Karagiannis A Clinical Trial Unit Bern, and Institute of Social and Preventive Medicine, University of Bern, Switzerland (A.K.).
• Windecker S Swiss Cardiovascular Center Bern, Bern University Hospital (S.A., S.W., M.V.).
• Valgimigli M Swiss Cardiovascular Center Bern, Bern University Hospital (S.A., S.W., M.V.).

Show more…

P2Y12 receptors

adenosine

dyspnea

ticagrelor

Acute Coronary Syndrome

Adenosine

Biomarkers

Cross-Over Studies

Drug Monitoring

Dyspnea

Humans

Platelet Aggregation

Platelet Aggregation Inhibitors

Platelet Function Tests

Prospective Studies

Purinergic P2Y Receptor Antagonists

Ticagrelor

Time Factors